Podcasts about rhinosinusitis

Aspirin or biologics? How do you choose the right treatment for AERD? On this episode of the BackTable ENT & Allergy Podcast, Dr. Basil Kahwash interviews Dr. Andrew White, Director of the AERD Clinic at Scripps Clinic, to discuss the diagnosis and management of this often underrecognized condition. They cover practical strategies for identifying AERD, the importance of a detailed NSAID history, and how treatment decisions are shaped by patient goals and disease severity. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction02:08 - What Is AERD and Prevalence 06:32 - History Taking and Mechanism 11:10 - Typical Symptom Progression and Alcohol Intolerance 16:41 - When to Do Aspirin Challenge 19:00 - Challenge Protocol And Upper Airway Reactions24:53 - Aspirin Desensitization vs Challenge27:58 - Aspirin therapy after desensitization and Risk of GI Bleeds31:17 - Biologics Change AERD33:42 - Choosing Aspirin Desensitization vs Biologics 35:52 - Patient Counseling and Motivational Interviewing 41:26 - Convenience and Cost of Therapy 44:10 - ENT Allergy Collaboration47:22 - Rapid Fire Pearls51:13 - Future Research & Management Direction54:05 - Final Takeaways --- More about this episode Dr. White explains that AERD affects about 8 to 10 percent of asthmatics, with even higher rates in those with severe asthma or nasal polyps. He reviews typical adult-onset progression, alcohol-related respiratory symptoms, and the underlying pathophysiology, including imbalances in arachidonic acid mediators and leukotriene surges after NSAID exposure.The conversation includes practical questions to ask when taking an NSAID history, such as reactions to common pain relievers or alcohol, and when to consider aspirin challenge. Dr. White also details long-term treatment strategies, including the role of biologics like dupilumab and aspirin therapy after desensitization, with considerations for dosing and gastrointestinal risk. He explains how factors like asthma severity, recurrent polyp disease, sense of smell, cost, and convenience all influence therapy choice. The episode concludes with a discussion of multidisciplinary collaboration, patient counseling, and Dr. White's insights on future research directions in AERD management. --- Resources Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthmahttps://pubmed.ncbi.nlm.nih.gov/16275362/ Polyphenolic Activation of Basophils Explains Alcohol Hypersensitivity in AERDhttps://pubmed.ncbi.nlm.nih.gov/41065188/ New insights into the mechanisms of aspirin-exacerbated respiratory diseasehttps://pubmed.ncbi.nlm.nih.gov/39641750/ The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunologyhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7980229/ Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center studyhttps://pubmed.ncbi.nlm.nih.gov/28550988/ Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory diseasehttps://pubmed.ncbi.nlm.nih.gov/17208597/ Factors influencing aspirin therapy after desensitization (ATAD) tolerance in aspirin-exacerbated respiratory disease (AERD) patientshttps://pubmed.ncbi.nlm.nih.gov/41022281/ Feed the Good Wolf: Motivational Interviewing, Cognitive Behavioral Therapy, and Mindsethttps://pubmed.ncbi.nlm.nih.gov/42103433/ --- BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

In this episode, host Dr. Kristine Smith speaks with Dr. Leigh Sowerby. They discuss the recently published Clinical Letter: “Evaluating the Potential Infectious Risk Profile of Biologics in Chronic Rhinosinusitis With Nasal Polyposis”. The full manuscript is available as open access in the International Forum of Allergy and Rhinology. Listen and subscribe for free to […]

Chronic rhinosinusitis without nasal polyps (CRSsNP) is the type that makes up most chronic sinusitis cases. It's often mistaken for allergies, a lingering cold, or migraines, which can delay a proper diagnosis for years. Dr. Gupta and Kortney sit down with Dr. Anju Peters, an allergist at Northwestern University's Feinberg School of Medicine, to unpack how this condition is actually diagnosed, why it can take patients years to get an answer, and which treatments have real evidence behind them. What we cover in this episode about chronic sinusitis without nasal polyps Two types of chronic sinusitis. About 75% of chronic sinusitis patients do not have nasal polyps, and about 20 to 25% do, and the treatment path differs depending on which type you have. Getting the right diagnosis. Doctors confirm chronic sinusitis without nasal polyps by combining at least 12 weeks of symptoms with objective proof of inflammation. Ruling out look-alikes. Allergies, colds, and migraines can all cause similar congestion and pressure, so doctors pay close attention to how long symptoms last and whether inflammation is actually confirmed. Building a treatment toolkit. Nasal steroid sprays are the backbone of treatment. When to consider surgery. When sinus surgery becomes the next step in sinus care. Resources: Ep. 133 What Is Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)? Ep. 149 What is Chronic Rhinosinusitis without Nasal Polyps Allergy & Asthma Network: chronic rhinosinusitis overview How is chronic rhinosinusitis diagnosed Treatment and management of chronic rhinosinusitis What is chronic rhinosinusitis with nasal polyps How to use the FDA-approved nasal spray *********** Made in partnership with The Allergy & Asthma Network. Thanks to Insmed for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute for professional medical advice. Always consult with your healthcare provider for any medical concerns.

Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author Ahmad Sedaghat, MD, and Associate Editor Jakob Fischer, MD, to discuss the overall symptom severity score that provides a global assessment of symptom burden associated with chronic rhinosinusitis, as outlined in the paper "Psychometric Validation of the Overall Symptom Severity Score for Chronic Rhinosinusitis" which published in the June 2026 issue of Otolaryngology–Head and Neck Surgery. Click here to read the full article.    

In this episode, host Dr. Dan Beswick speaks with Drs. Mark Citardi and Daniel Xiao. They discuss the recently published Research Note: “Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps”. The full manuscript is available in the International Forum of Allergy and Rhinology. Listen and […]

In this episode of Better Edge, Kevin C. Welch, MD, professor of Otolaryngology–Head and Neck Surgery at Northwestern Medicine, talks about his recent study that evaluated if endoscopic sinus surgery affects the long term risk of asthma and bronchiectasis in patients with chronic rhinosinusitis. Drawing from a large retrospective cohort with extended follow up, the study explored differences in outcomes by disease severity and nasal polyp status. The episode also highlights how these findings may inform clinical decision making and patient counseling in the management of refractory CRS.

Chronic sinusitis without nasal polyps is the most common form of chronic sinusitis. Even so, most patients spend years without a clear explanation, cycling through antibiotics that do not address what is actually going on. In this episode, Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss and Dr. Anju Peters, an allergist and immunologist at Northwestern University who co-authored the 2025 Adult Sinusitis Clinical Practice Guideline. Together, they break down what chronic sinusitis without nasal polyps (CRSsNP) actually is, what the real quality-of-life impact looks like, and how a proper diagnosis is confirmed. What we cover in this episode about chronic rhinosinusitis without nasal polyps Not an infection. Chronic sinusitis without nasal polyps is driven by inflammation lasting 12 weeks or more, not by bacteria or a virus, which is why antibiotics often do not help. The hidden quality of life burden. Beyond congestion and sinus pressure, patients commonly experience fatigue, poor sleep, anxiety, depression, and social isolation. Why so many patients go years without a correct diagnosis. Symptoms overlap significantly with conditions like allergic rhinitis or migraines. Many patients adapt to feeling unwell rather than seeking answers. How doctors confirm the diagnosis. A diagnosis requires objective evidence of inflammation, as seen on nasal endoscopy or a CT scan of the sinuses, not symptoms alone. The connection between sinusitis and asthma. The nose, sinuses, and lungs share one connected airway, and about 60% of people with this condition also have asthma, with each capable of making the other worse. *********** Made in partnership with The Allergy & Asthma Network. Thanks to Insmed for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Glenmark to launch the first generic version of Flovent HFA, expanding affordable access; achondroplasia treatment granted accelerated approval; Dupixent approved for allergic fungal rhinosinusitis; and a swallowable balloon offers a unique outpatient alternative for weight management.

Chronic rhinosinusitis with nasal polyps, or CRSwNP, is a condition driven by ongoing inflammation. That is why treatment is not a one-time fix and why polyps can come back even after surgery. In this episode, Dr. Payel Gupta and Kortney are joined by Dr. Maeve O'Connor, a board-certified allergist and immunologist, to walk through CRSwNP treatment options. This episode is released around World Anosmia Day because loss of smell is one of the most frustrating and most common symptoms of CRSwNP, and one that treatment can actually help with. What we cover in this episode about nasal polyps treatment Nasal therapies as your base management: Saline rinses and nasal steroid sprays are the foundation of CRSwNP treatment. They need to be used consistently as part of your daily routine, not just when symptoms flare. Why nasal polyps keep coming back: CRSwNP is driven by ongoing inflammation, not just the polyps themselves, so removing them does not address the root cause. When surgery is the right choice: Sinus surgery can open blocked passages and help nasal sprays reach deeper into the sinuses, but works best as part of a long-term plan, not a one-time fix. What biologic medications actually do: Biologics target the underlying inflammation causing CRSwNP. Four are currently approved for CRSwNP: dupilumab, omalizumab, mepolizumab, and tezepelumab. Why follow-up care matters even when you feel better: Inflammation can return before symptoms become noticeable, so regular check-ins with your allergist or ENT are key to catching early signs of polyp regrowth. About our guest  Dr. Maeve O'Connor, MD, FACAAI, FAAAAI, is a board-certified allergist and immunologist and founder of Allergy Asthma & Immunology Relief (AAIR) of Charlotte, North Carolina. She treats patients of all ages, practices integrative medicine, and has been named a Top Doctor by Charlotte Magazine since 2007. More resources What is Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)? What are nasal polyps? What is AERD? Biologics for Allergic Disease What to know before starting a biologic  Oral Corticosteroid Stewardship   ********* Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi-Regeneron for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In this episode, host Dr. Dan Beswick speaks with Dr. Waleed Abuzeid. They discuss the recently published Original Article: “Predicting Surgical Outcomes in Chronic Rhinosinusitis From Preoperative Patient Data: A Machine Learning Approach.” The full manuscript is available in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out […]

Persistent congestion, pressure, or a reduced sense of smell often gets mistaken for allergies or a stubborn cold when it may be something more, like chronic rhinosinusitis with nasal polyps (CRSwNP). Getting the right diagnosis is the first step toward real relief. Dr. Tonya Farmer, a board-certified ENT, joins Kortney and Dr. G to explain how chronic rhinosinusitis with nasal polyps (CRSwNP) is diagnosed. She walks us through the full evaluation: what symptoms matter, what a nasal endoscopy actually shows, when a CT scan is needed, and how type 2 inflammation fits into the picture. What we cover about diagnosing CRSwNP: Key symptoms: Persistent congestion, drainage, facial pressure, and especially loss of smell are major red flags for CRSwNP. Why duration matters: Chronic means 12 weeks or longer. If symptoms keep coming back or never truly improve, it's time to look deeper. The physical exam: ENTs use nasal endoscopy to see swelling, mucus, or polyps that aren't visible from the outside. When CT scans are needed: Imaging helps confirm sinus inflammation and shows the extent of polyp growth. Additional testing: Allergy testing, IgE levels, eosinophils, and other immune markers help identify type 2 inflammation and guide next steps. When to see a specialist: If antibiotics, steroids, or over-the-counter treatments aren't helping, ask for a referral to an allergist or ENT. Early diagnosis can prevent worsening symptoms and reduce the need for surgery. Set the foundations: Ep. 133: What is Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)? ___   Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

In Western countries, type 2 inflammation is the underlying cause of CRSwNP in ~ 80% of patients. Credit available for this activity expires: 10/24/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-rhinosinusitis-nasal-polyps-reimagined-bridging-2025a1000saf?ecd=bdc_podcast_libsyn_mscpedu

Living with constant congestion, facial pressure, or a loss of smell can make daily life exhausting. For many people, these symptoms are more than just allergies or a lingering cold. They may be signs of chronic rhinosinusitis with nasal polyps (CRSwNP). Dr. Rohit Katial joins Kortney and Dr. G to unpack what CRSwNP really is, how it develops, and why type 2 inflammation plays such a key role. Together, they explain what's happening inside the sinuses, what symptoms to look for, and when it's time to see a specialist. What we cover about CRSwNP: What CRSwNP means: Chronic rhinosinusitis with nasal polyps is long-term inflammation of the nose and sinuses that lasts 12 weeks or more. What nasal polyps are: Soft, fluid-filled sacs (often “grape” or “pea” sized) that block airflow and lead to congestion and smell loss. Why it happens: Type 2 inflammation drives CRSwNP. Immune messengers like IL-4, IL-5, and IL-13 cause swelling and fluid buildup in the nasal lining. Who it affects: CRSwNP often overlaps with asthma, allergies, or aspirin sensitivity (AERD or Samter's Triad), making symptoms worse. When to seek help: If congestion, pressure, or loss of smell lasts more than 12 weeks, see an allergist or an ENT specialist. Early care can prevent sinus damage and improve breathing and quality of life. More episodes to support CRSwNP Ep. 101: What is Type 2 Inflammation? Ep. 102: Comorbidities of Type 2 Inflammation -  Connecting the Dots Between Multiple Allergic Conditions Ep. 109: Tezepelumab & Nasal Polyps - Inside the WAYPOINT Phase III Trial ___ Made in partnership with The Allergy & Asthma Network. Thanks to AstraZeneca for sponsoring today's episode.  This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from August 16-22 2025.

In this episode, host Dr. Dan Beswick speaks with Drs. Peter Hwang, Lirit Levi, and Amir Levi. They discuss the recently published Original Article: “Association between US Wildfires and Health Care Utilization for Acute Rhinosinusitis.” The full manuscript is available as open access in the International Forum of Allergy and Rhinology. Listen and subscribe for […]

How do we integrate biologics into the existing stepwise treatment model for chronic rhinosinusitis with nasal polyps (CRSwNP)? In this episode, Dr. Reena Mehta, an allergist from Uptown Allergy and Asthma in New Orleans, discusses the use of biologics for treating chronic rhinosinusitis with nasal polyps. ---SYNPOSISDr. Mehta elaborates on the common presentations of patients, the role of biologics such as dupilumab and tezepelumab, and the nuances of patient management post-sinus surgery. Dr. Mehta also covers the workup process, the significance of patient comorbidities like asthma and allergies, and the future perspectives on biologic treatments. Practical aspects of biologic therapy, including insurance hurdles, patient compliance, and the effectiveness of various biologics are thoroughly examined.---TIMESTAMPS00:00 - Introduction 02:27 - Understanding Chronic Rhinosinusitis with Nasal Polyps & Presentation05:22 - Workup and Management of Nasal Polyps07:31 - Treatment Options: Steroids and Biologics15:28 - Tezepelumab: A New Tool in the Toolkit25:03 - Side Effects and Safety of Biologics28:59 - Insurance and Approval Challenges36:14 - Long-Term Safety and Efficacy38:47 - Pediatric Considerations and Future Directions41:37 - Collaboration Between ENT and Allergy Specialists45:07 - Conclusion and Final Thoughts---RESOURCESDr. Reena Mehtahttps://uptownallergyasthma.com/allergist-dr-reena-mehta/

In this episode, host Dr. Sarah Wise speaks with Dr. Naweed Chowdhury. They discuss the recently published Original Article: “Long-Term Particulate Matter Exposure May Increase Risk of Chronic Rhinosinusitis With Nasal Polyposis: Results from an Exposure-Matched Study.” The full manuscript is available as open access in the International Forum of Allergy and Rhinology. Listen and […]

In this episode of Better Edge, Bruce K. Tan, MD, discusses the newest clinical practice guidelines for the surgical management of chronic rhinosinusitis (CRS). Dr. Tan covers how treatment paradigms have evolved over the past 15 years, from antibiotic-centric approaches to multifaceted strategies that recognize CRS as a complex inflammatory condition. He dives into the guidelines' recommendations on diagnoses, biologic therapies and multidisciplinary collaboration. Additionally, Dr. Tan shares insights on future directions for research and the promise of precision medicine in tailoring effective treatments for a range of patient profiles.

Editor-in-Chief Cecelia E. Schmalbach, MD, MSc, is joined by authors Meghan Wilson, MD, and Jason Blakeley Hensler, MD, to discuss information on when to consider moving forward with surgical interventions for those who are evaluated and diagnosed with chronic rhinosinusitis. Based on the 2025 “Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis” and is a companion publication to the full guideline. Click here to read the full article.

Editor-in-Chief Cecelia E. Schmalbach, MD, MSc is joined by the guideline group's chair Jennifer J. Shin, MD, SM, and co-author Dana Crosby, MD, MPH, for a discussion of key points from the “Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis,” which published as a supplement to the June 2025 issue of Otolaryngology–Head and Neck Surgery. The guideline addresses critical questions about patient selection, timing of surgery, and the extent of surgical intervention needed for different chronic rhinosinusitis subtypes.  Read the full article here.

In this episode, host Dr. Doug Reh speaks with Dr. Josh Levy. They discuss the recently published Review Article: “Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary Workshop”. The full manuscript is available online in the International Forum of Allergy and Rhinology. Listen and subscribe for free to […]

In this episode, host Dr. Sarah Wise speaks with Dr. Do-Yeon Cho and Dr. Brad Woodworth. They discuss the recently published Research Note: “Prevalence of Cystic Fibrosis Carrier Status in Chronic Rhinosinusitis Without Nasal Polyp”. The full manuscript is available online as Open Access in the International Forum of Allergy and Rhinology. Listen and subscribe […]

In this episode, host Dr. Doug Reh speaks with Dr. Mathew Geltzeiler. They discuss the recently published Original Article: “Rate of dupilumab use and symptom severity of patients with chronic rhinosinusitis with nasal polyposis after Draf 3 frontal sinusotomy”. The full manuscript is available online in the International Forum of Allergy and Rhinology. Listen and […]

Please visit answersincme.com/YWD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in rhinology discusses the use of biologics for the management of chronic rhinosinusitis with nasal polyps (CRSwNP). Upon completion of this activity, participants should be better able to: Identify key considerations for initiating a biologic therapy in patients with CRSwNP; Discuss the clinical impact of the latest data for novel approved biologics in CRSwNP; and Apply best practice approaches for management of biologics in patients with CRSwNP. This activity is intended for US healthcare professionals only.

In this episode, host Dr. Marc Dubin speaks with Dr. Peter Manes. They discuss the recently published Original Article: “Assessment of conflicts of interest in literature on monoclonal antibodies for chronic rhinosinusitis with nasal polyposis using the Open Payments Database”. The full manuscript is available online in the International Forum of Allergy and Rhinology. Listen […]

In this episode, host Dr. Sarah Wise speaks with Dr. Chadi Makary. They discuss the recently published Review Article: “Evaluation and treatment of rhinosinusitis with primary antibody deficiency in children: Evidence-based review with recommendations”. The full manuscript is available online in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope […]

In this episode, host Dr. Doug Reh speaks with Dr. Eugene Chang. They discuss the recently published Research Article: “A prospective longitudinal study assessing the impact of rhinovirus and bacterial infections in acute exacerbations of chronic rhinosinusitis”. The full manuscript is available online in the International Forum of Allergy and Rhinology. Listen and subscribe for […]

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by author Ahmad R. Sedaghat MD, PhD, and Associate Editor Dana L. Crosby, MD, MPH, to discuss the possibility of chronic rhinosinusitis when allergies are assumed as outlined in the paper “When It's Not Allergic Rhinitis: Clinical Signs to Raise a Patient's Suspicion for Chronic Rhinosinusitis” which published in the September 2024 issue of Otolaryngology–Head and Neck Surgery. They compare the symptoms of chronic rhinosinusitis to those of allergies or related conditions, and where there is overlap.  Click here to read the full article.

In this episode, host Dr. Amber Luong speaks with Dr. Amin Javer. They discuss the recently published Research Note: “SinoNasal Microbiota Transfer to treat recalcitrant chronic rhinosinusitis: A case series”. The full manuscript is available as Open Access in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out […]

In this episode, host Dr. Marc Dubin speaks with Dr. Vinay Rathi. They discuss the recently published Research Note: Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries. Read the full article in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out […]

Klinisch Relevant ist Dein Wissenspartner für das Gesundheitswesen. Drei mal pro Woche, nämlich dienstags, donnerstags und samstags, versorgen wir Dich mit unserem Podcast und liefern Dir Fachwissen für Deine klinische Praxis. Weitere Infos findest Du unter https://klinisch-relevant.de

In this episode, host Dr. Doug Reh speaks with Dr. Rod Schlosser. They discuss the recently published article: Surgical management of headache and facial pain/pressure in chronic rhinosinusitis: A systematic review and meta-analysis. Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out on Apple Podcasts, Google […]

In this episode, host Dr. Amber Luong speaks with Dr. Sarina Mueller They discuss the recently published article: Comparison of mucus and serum biomarker sampling in chronic rhinosinusitis with nasal polyps. Read the fully open access article in the International Forum of Allergy and Rhinology. Listen and subscribe for free to Scope It Out on Apple […]

Nasal spray approved for chronic rhinosinusitis; Endothelin receptor antagonist gains approval to lower blood pressure in hypertension; One-time stem cell treatment approved for metachromatic leukodystrophy; NASH treatment gains accelerated approval; New automated insulin delivery system for type 1 diabetes.  

In this episode, host Dr. Sarah Wise speaks with Dr. Amarbir Gill. They discuss his recently published article: Health care disparities and chronic rhinosinusitis: Does neighborhood disadvantage impact outcomes in sinonasal disease? Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

In this episode, host Dr. Amber Luong speaks with Dr. Ahmad Sedaghat. They discuss his recently published article: Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control. Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe […]

In this episode, host Dr. Marc Dubin speaks with Dr. Gurston Nyquist. They discuss his recently published article: Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP). Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe […]

Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.65 AANP, including 0.65 AANP Pharm   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/acute-bacterial-rhinosinusitis    Overview: In this 30-minute podcast tailored for medical professionals, navigate the nuances of Acute Bacterial Rhinosinusitis (ABRS) as expert faculty discuss differentiating symptoms from acute rhinosinusitis. Gain practical insights on constructing effective treatment plans for ABRS in adults and acute bacterial sinusitis in pediatric populations, offering valuable guidance for appropriate antibiotic use in these scenarios. Stay informed and enhance your clinical decision-making skills in managing these common conditions.   Guest: Danielle Hebert, DNP, MBA, ANP-BC

In this episode, host Dr. Sarah Wise speaks with Dr. Bobby Tajudeen. They discuss his recently published article: Histopathologic features of biologic therapy nonresponders in chronic rhinosinusitis with nasal polyposis. Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

On this episode, my good friend and colleague Alex Hovey, PA-C is sitting in for Cole this episode. We review the treatment of acute rhinosinusitis and pharyngitis. We mention some treatment options for symptom relief in patients with viral sinusitis and viral pharyngitis. We spend the majority of the episode covering the treatment algorithm for bacterial sinusitis and pharyngitis. We also used this episode to review some antibiotic clinical pearls.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! We want to give a big thanks to our sponsor, High-Powered Medicine. HPM is a book/website database of summaries for over 150 landmark clinical trials. You can get a copy of HPM, written by Dr. Alex Poppen, PharmD, at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx  This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

In this episode, host Dr. Doug Reh speaks with Dr. Lauren Roland and Dr. Edward Kuan. They discuss their recently published article: Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence-Based Review with Recommendations Read the article in the International Forum of Allergy and Rhinology. Listen and subscribe for free […]

In this episode, host Dr. Mark Dubin speaks with Dr. Jose Mattos and Dr. Spencer Payne. They discuss their recently published article: Evaluation and workup of immunodeficiencies in recurrent acute rhinosinusitis: A scoping review. Please note that an unedited version of this episode posted in error earlier this month. Wiley sincerely apologizes for this error. […]

Commissioned by the Allergy, Asthma and Immunology Committee, Joshua M Levy, MD, MPH and Bruce K. Tan, MD discuss mechanisms and biomarkers of endotypes in chronic rhinosinusitis. Subjects covered by this podcast include identification of types of inflammation, geographic variations in endotypes, and methods utilized to address different endotypes.

JAMA Pediatrics Editors' Summary by Dimitri A. Christakis, MD, MPH, Editor in Chief, and Alison A. Galbraith, MD, MPH, Associate Editor, for the April 3, 2023, issue. Related Content: Effect of an Intranasal Corticosteroid on Quality of Life and Local Microbiome in Young Children With Chronic Rhinosinusitis Changes in Body Mass Index Among School-Aged Youths Following Implementation of the Healthy, Hunger-Free Kids Act of 2010

Matt Rank, MD, FAAAAI, the lead author of new guidelines for chronic rhinosinusitis with nasal polyposis, offers tremendous insight regarding these recommendations and how to apply them to clinical care.

In this episode, host Dr. Amber Luong speaks with Dr. Amar Miglani. They will discuss article: A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Read the article in International Forum of Allergy and Rhinology. Listen and subscribe for free on Apple Podcasts , Google Podcasts and Subscribe on Android.

Refer to headmirror.com (www.headmirror.com/toc-podcast) to review all podcasts, organized by subspecialty topic and searchable by keywords.

In episode 514, James and Mike invite Betsy Thomas to the podcast for the first time. We look at a very common condition that many of us have at some point in our lives – allergic rhinosinusitis. We go over the best available evidence for the oral antihistamines and try to figure out which one […]

Refer to headmirror.com (www.headmirror.com/toc-podcast) to review all podcasts, organized by subspecialty topic and searchable by keywords.